New study aims to bring better diabetes control to Bangladesh's cities
NCT ID NCT07155902
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a community-to-facility care model to help control type 2 diabetes in Bangladesh. Researchers will compare the new integrated approach with usual care in 20 city wards involving 5,000 adults. The goal is to see if linking community health workers with clinics improves diabetes management and prevention.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- community-to-facility integrated care strategy
- What this could lead to
- If successful, this could show how to better manage and prevent type 2 diabetes in urban poor communities in low-income countries.
- What could go wrong
- This is an implementation study, not a drug trial, so it tests a care model rather than a new treatment. Results may not apply to other settings or populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES (T2DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection outperform semaglutide for diabetes remission?
- Can a drop of blood predict disease years before it strikes?
- Fatty liver may be a hidden driver of heart attacks in diabetes
- Could date seed powder help tame type 2 diabetes?
- Triple-Drug combo aims to improve diabetes control and weight loss
- Could a wearable sensor transform early diabetes care?